ACADIA Pharmaceuticals
ACAD
#3247
Rank
S$6.44 B
Marketcap
S$37.62
Share price
0.62%
Change (1 day)
17.83%
Change (1 year)

Market capitalization of ACADIA Pharmaceuticals (ACAD)

Market cap: S$6.44 Billion

As of August 2026 ACADIA Pharmaceuticals has a market cap of S$6.44 Billion. This makes ACADIA Pharmaceuticals the world's 3247th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ACADIA Pharmaceuticals from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026S$6.44 B10.31%
2025S$5.84 B40.46%
2024S$4.15 B-38.75%
2023S$6.78 B96.44%
2022S$3.45 B-31.87%
2021S$5.07 B-54.89%
2020S$11.24 B25.55%
2019S$8.95 B181.81%
2018S$3.17 B-36.47%
2017S$5.00 B-1.05%
2016S$5.05 B-1.66%
2015S$5.14 B22.47%
2014S$4.19 B45.51%
2013S$2.88 B591.7%
2012S$0.41 B464.68%
2011S$73.85 M21.41%
2010S$60.82 M-14.37%
2009S$71.03 M48.45%
2008S$47.85 M-91.89%
2007S$0.58 B46.19%
2006S$0.40 B46.07%
2005S$0.27 B48.49%
2004S$0.18 B

End of Day market cap according to different sources

On Aug 10th, 2026 the market cap of ACADIA Pharmaceuticals was reported to be:

S$6.48 Billion
by Nasdaq info icon info icon
S$6.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$807.71 B 12,436.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$197.37 B 2,963.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.405 T 21,719.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$169.55 B 2,531.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
S$0.38 B-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
S$0.48 B-92.52%๐Ÿ‡บ๐Ÿ‡ธ USA